J. Michael Pearson

2015 - Valeant Pharmaceuticals International

In 2015, J. Michael Pearson earned a total compensation of $143.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 1,279% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,000,000
Stock Awards$140,304,682
Other$772,760
Total$143,077,442

Pearson received $140.3M in stock awards, accounting for 98.06% of the total pay in 2015.

Pearson also received $2M in non-equity incentive plan and $772.8K in other compensation.

Rankings

In 2015, J. Michael Pearson's compensation ranked 2nd out of 13,622 executives tracked by ExecPay.

ClassificationRankingPercentile
All
2
out of 13,622
100th
Division
Manufacturing
2
out of 5,195
100th
Major group
Chemicals And Allied Products
2
out of 1,824
100th
Industry group
Drugs
2
out of 1,493
100th
Industry
Pharmaceutical Preparations
1
out of 1,153
100th
Source: SEC filing on April 29, 2016.

Pearson's colleagues

We found six more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2015.

2015

Robert Rosiello

Valeant Pharmaceuticals International

Chief Financial Officer

2015

Anne Whitaker

Valeant Pharmaceuticals International

Group Chairman

2015

Brian Stolz

Valeant Pharmaceuticals International

Senior Vice President and General Manager

2015

Debora Jorn

Valeant Pharmaceuticals International

Group Chairman

2015

Ari Kellen

Valeant Pharmaceuticals International

Group Chairman

2015

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

You may also like